Literature DB >> 23578692

Acceptor specificities and selective inhibition of recombinant human Gal- and GlcNAc-transferases that synthesize core structures 1, 2, 3 and 4 of O-glycans.

Yin Gao1, Rajindra P Aryal, Tongzhong Ju, Richard D Cummings, Gagandeep Gahlay, Donald L Jarvis, Khushi L Matta, Jason Z Vlahakis, Walter A Szarek, Inka Brockhausen.   

Abstract

BACKGROUND: Modifications of proteins by O-glycosylation determine many of the properties and functions of proteins. We wish to understand the mechanisms of O-glycosylation and develop inhibitors that could affect glycoprotein functions and alter cellular behavior.
METHODS: We expressed recombinant soluble human Gal- and GlcNAc-transferases that synthesize the O-glycan cores 1 to 4 and are critical for the overall structures of O-glycans. We determined the properties and substrate specificities of these enzymes using synthetic acceptor substrate analogs. Compounds that were inactive as substrates were tested as inhibitors.
RESULTS: Enzymes significantly differed in their recognition of the sugar moieties and aglycone groups of substrates. Core 1 synthase was active with glycopeptide substrates but GlcNAc-transferases preferred substrates with hydrophobic aglycone groups. Chemical modifications of the acceptors shed light on enzyme-substrate interactions. Core 1 synthase was weakly inhibited by its substrate analog benzyl 2-butanamido-2-deoxy-α-d-galactoside while two of the three GlcNAc-transferases were selectively and potently inhibited by bis-imidazolium salts which are not substrate analogs.
CONCLUSIONS: This work delineates the distinct specificities and properties of the enzymes that synthesize the common O-glycan core structures 1 to 4. New inhibitors were found that could selectively inhibit the synthesis of cores 1, 2 and 3 but not core 4. GENERAL SIGNIFICANCE: These studies help our understanding of the mechanisms of action of enzymes critical for O-glycosylation. The results may be useful for the re-engineering of O-glycosylation to determine the roles of O-glycans and the enzymes critical for O-glycosylation, and for biotechnology with potential therapeutic applications.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23578692      PMCID: PMC4002258          DOI: 10.1016/j.bbagen.2013.04.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  53 in total

Review 1.  Selectins promote tumor metastasis.

Authors:  Heinz Läubli; Lubor Borsig
Journal:  Semin Cancer Biol       Date:  2010-05-07       Impact factor: 15.707

2.  Cosmc is an essential chaperone for correct protein O-glycosylation.

Authors:  Yingchun Wang; Tongzhong Ju; Xiaokun Ding; Baoyun Xia; Wenyi Wang; Lijun Xia; Miao He; Richard D Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

3.  Specificity of β1,4-galactosyltransferase inhibition by 2-naphthyl 2-butanamido-2-deoxy-1-thio-β-D-glucopyranoside.

Authors:  Yin Gao; Carmen Lazar; Walter A Szarek; Inka Brockhausen
Journal:  Glycoconj J       Date:  2010-10-26       Impact factor: 2.916

4.  Structural and mechanistic characterization of leukocyte-type core 2 β1,6-N-acetylglucosaminyltransferase: a metal-ion-independent GT-A glycosyltransferase.

Authors:  John E Pak; Malathy Satkunarajah; Jayaraman Seetharaman; James M Rini
Journal:  J Mol Biol       Date:  2011-10-26       Impact factor: 5.469

5.  Random glycopeptide bead libraries for seromic biomarker discovery.

Authors:  Stjepan K Kracun; Emiliano Cló; Henrik Clausen; Steven B Levery; Knud J Jensen; Ola Blixt
Journal:  J Proteome Res       Date:  2010-11-02       Impact factor: 4.466

6.  Anti-Plasmodium activity of imidazolium and triazolium salts.

Authors:  Jason Z Vlahakis; Carmen Lazar; Ian E Crandall; Walter A Szarek
Journal:  Bioorg Med Chem       Date:  2010-05-12       Impact factor: 3.641

Review 7.  Baculovirus-insect cell expression systems.

Authors:  Donald L Jarvis
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

8.  Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.

Authors:  Inka Brockhausen; Thomas Dowler; Hans Paulsen
Journal:  Biochim Biophys Acta       Date:  2009-06-11

9.  C2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells.

Authors:  Catherine A St Hill; Dahabo Baharo-Hassan; Mariya Farooqui
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

Review 10.  The Tn antigen-structural simplicity and biological complexity.

Authors:  Tongzhong Ju; Vivianne I Otto; Richard D Cummings
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-21       Impact factor: 15.336

View more
  4 in total

1.  Characterization of two UDP-Gal:GalNAc-diphosphate-lipid β1,3-galactosyltransferases WbwC from Escherichia coli serotypes O104 and O5.

Authors:  Shuo Wang; Diana Czuchry; Bin Liu; Anna N Vinnikova; Yin Gao; Jason Z Vlahakis; Walter A Szarek; Lei Wang; Lu Feng; Inka Brockhausen
Journal:  J Bacteriol       Date:  2014-06-23       Impact factor: 3.490

2.  Biosynthesis of the Common Polysaccharide Antigen of Pseudomonas aeruginosa PAO1: Characterization and Role of GDP-D-Rhamnose:GlcNAc/GalNAc-Diphosphate-Lipid α1,3-D-Rhamnosyltransferase WbpZ.

Authors:  Shuo Wang; Youai Hao; Joseph S Lam; Jason Z Vlahakis; Walter A Szarek; Anna Vinnikova; Vladimir V Veselovsky; Inka Brockhausen
Journal:  J Bacteriol       Date:  2015-04-06       Impact factor: 3.490

Review 3.  Crossroads between Bacterial and Mammalian Glycosyltransferases.

Authors:  Inka Brockhausen
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

4.  A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis.

Authors:  Rohitesh Gupta; Frank Leon; Sanchita Rauth; Surinder K Batra; Moorthy P Ponnusamy
Journal:  Cells       Date:  2020-02-14       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.